ProfileGDS4132 / 206022_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 25% 27% 21% 19% 21% 29% 28% 24% 14% 21% 17% 16% 19% 15% 17% 20% 13% 16% 13% 25% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10159.816125
GSM201543Muscle PCOS pioglitazone 12156.803527
GSM201544Muscle PCOS pioglitazone 16147.858821
GSM201545Muscle PCOS pioglitazone 20145.467119
GSM201829Muscle PCOS pioglitazone 23148.999221
GSM201830Muscle PCOS pioglitazon 25171.787629
GSM201831Muscle PCOS pioglitazone 27166.621328
GSM201832Muscle PCOS pioglitazone 3156.749424
GSM201833Muscle PCOS pioglitazone 4126.447814
GSM201834Muscle PCOS pioglitazone 8144.088921
GSM201835Muscle PCOS after pioglitazone 10227.326317
GSM201836Muscle PCOS after pioglitazone 12227.803716
GSM201837Muscle PCOS after pioglitazone 16232.945719
GSM201838Muscle PCOS after pioglitazone 20226.543115
GSM201839Muscle PCOS after pioglitazone 23231.79817
GSM201840Muscle PCOS after pioglitazone 25242.488920
GSM201841Muscle PCOS after pioglitazone 27220.162513
GSM201842Muscle PCOS after pioglitazone 3224.816416
GSM201843Muscle PCOS after pioglitazone 4227.009513
GSM201844Muscle PCOS after pioglitazone 8253.549125